Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · IEX Real-Time Price · USD
14.99
-0.38 (-2.47%)
At close: Jul 19, 2024, 4:00 PM
14.98
-0.01 (-0.07%)
After-hours: Jul 20, 2024, 12:57 PM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $402.99 million as of July 22, 2024.
Market Cap
402.99M
Enterprise Value
207.06M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.99
Market Cap Chart
Since the IPO on February 2, 2024, Alto Neuroscience's market cap has decreased from $409.04M to $402.99M, a decrease of -1.48%. That is a compound annual growth rate of -3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 403.00M | -1.48% |
| Feb 2, 2024 | 409.04M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 411.19M |
| Anika Therapeutics | 409.47M |
| Sonida Senior Living | 407.46M |
| Esperion Therapeutics | 407.30M |
| Cerus | 406.76M |
| Precigen | 401.35M |
| AxoGen | 398.59M |
| Lyell Immunopharma | 397.70M |